Clinical implications of interleukins-31, 32, and 33 in gastric cancer

Table 2 Univariate and multivariate analyses of clinicopathological factors affecting survival of patients with gastric cancer at T4 stage

Variables analysis	Univariate HR (95%CI)	P value	Multivariate HR (95%CI)	P value
IL-32 (low/high)	4.338 (1.450-12.980)	0.009	3.287 (1.024-10.555)	0.046
Tumour differentiation (low/moderate)	0.710 (0.225-2.237)	0.559
TNM		0.008		0.037
IV (reference)	1		1
II	0.034 (0.003-0.423)	0.008	0.069 (0.005-0.946)	0.045
III	0.203 (0.018-0.464)	0.004	0.127 (0.025-0.646)	0.013
Lymph node metastasis (no/yes)	0.441 (0.098-1.982)	0.285
Diameter (< 5/≥ 5, cm)	0.475 (0.161-1.404)	0.178
Female/male	0.912 (0.323-2.573)	0.862
Age (≤ 60/> 60)	1.950 (0.688-5.529)	0.209